Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Prince

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Haematologica|September 21, 2023
Outcome heterogeneity of <i>TP53</i>-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantationSergiu Pasca, Saurav D Haldar, Alexander Ambinder, et al.
Blood Neoplasia|September 15, 2025
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AMLAndrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2020
Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection StudyJames G Kublin, Sean C Murphy, Janine Maenza, et al.
Leukemia|January 30, 2014
Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissuesM Goswami, N Hensel, B D Smith, et al.
Blood Advances|April 19, 2024
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndromeCourtney D DiNardo, Gail J Roboz, Justin M Watts, et al.
Leukemia|January 5, 2020
Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDSJoshua F Zeidner, Hanna A Knaus, Amer M Zeidan, et al.
Blood Cancer Discovery|November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaJoshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Nature Communications|December 5, 2020
Evidence of exposure to SARS-CoV-2 in cats and dogs from households in ItalyE I Patterson, G Elia, A Grassi, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Evidence of exposure to SARS-CoV-2 in cats and dogs from households in ItalyE I Patterson, G Elia, A Grassi, et al.
Physical Review Letters|July 9, 2020
Candidate Electromagnetic Counterpart to the Binary Black Hole Merger Gravitational-Wave Event S190521gM J Graham, K E S Ford, B McKernan, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Haematologica|September 21, 2023
Outcome heterogeneity of <i>TP53</i>-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantationSergiu Pasca, Saurav D Haldar, Alexander Ambinder, et al.
Blood Neoplasia|September 15, 2025
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AMLAndrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2020
Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection StudyJames G Kublin, Sean C Murphy, Janine Maenza, et al.
Leukemia|January 30, 2014
Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissuesM Goswami, N Hensel, B D Smith, et al.
Blood Advances|April 19, 2024
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndromeCourtney D DiNardo, Gail J Roboz, Justin M Watts, et al.
Leukemia|January 5, 2020
Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDSJoshua F Zeidner, Hanna A Knaus, Amer M Zeidan, et al.
Blood Cancer Discovery|November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaJoshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Nature Communications|December 5, 2020
Evidence of exposure to SARS-CoV-2 in cats and dogs from households in ItalyE I Patterson, G Elia, A Grassi, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Evidence of exposure to SARS-CoV-2 in cats and dogs from households in ItalyE I Patterson, G Elia, A Grassi, et al.
Physical Review Letters|July 9, 2020
Candidate Electromagnetic Counterpart to the Binary Black Hole Merger Gravitational-Wave Event S190521gM J Graham, K E S Ford, B McKernan, et al.
Pageof 17